Peetz Christopher

CHIEF EXECUTIVE OFFICER, DirectorMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.9M
Net Open-Market Flow
-$2.9M
Transactions
8
7 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)30K$2.94$88K224K
Jun 1, 2026Sell(S)3K$94.64$246K222K
Jun 1, 2026Sell(S)17K$95.34$1.6M205K
Jun 1, 2026Sell(S)7K$96.15$666K198K
Jun 1, 2026Sell(S)2K$97.56$192K196K
Jun 1, 2026Sell(S)1K$98.20$100K195K
Jun 1, 2026Sell(S)883$99.66$88K194K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)30K$0128K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001614740-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly: